Oryzon Genomics SA (ES:ORY) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Oryzon Genomics S.A. has announced the registration of the deed of execution for its capital increase via convertible bonds in the Commercial Registry of Madrid.
For further insights into ES:ORY stock, check out TipRanks’ Stock Analysis page.
